Bimal Chaudhari, MD, MPH

Bimal Chaudhari

Contact Information

Biography

Bimal Chaudhari, MD, MPH, is a neonatologist, medical geneticist and translational informaticist. His clinical focus is on the application of rapid genome sequencing in acute and critical care settings. He is also an Associate Director of biomedical informatics at the NCH-OSU CTSA, chair of the Children's Hospital's Neonatal Consortium Genomics Focus Group, and chair of the American College of Medical Genetics and Genomics (ACMG) Systematic Evidence Review for Rapid Genome Sequencing in ICUs. Additionally, he is a clinical ethicist and a member of the Nationwide Children's and ACMG Ethics Committees as well as the Global Alliance for Genomics and Health Regulatory and Ethics Workstream.

Academic and Clinical Areas
Awards, Honors & Organizations
  • Teacher of the Year, Genetics Residency, 2022
  • Teacher of the Year, Genetics Residency, 2020
  • Fellow, Section on Neonatal-Perinatal Medicine, Section on Bioethics, Council on Genetics, Council on Clinical Information Technology, American Academy of Pediatrics
  • Member, American Medical Informatics Association
  • Fellow, American College of Medical Genetics and Genomics
  • Member, Society for Inherited Metabolic Disorders
  • Journal Reviewer, Journal of Pediatrics, Journal of the American Medical Informatics Association, Pediatric Neurology, Journal of Clinical Medicine
Education

Date of Appointment at Nationwide Children’s Hospital: 09/27/2019

Board Certifications
  • Neonatal-Perinatal Medicine
  • Clinical Genetics and Genomics (MD)
  • Pediatrics
Fellowship Ann & Robert H. Lurie Children's Hospital of Chica Date Completed: 06/30/2018
Residency Nationwide Children's Hospital Date Completed: 06/30/2019
Residency Magee Women's Hospital Date Completed: 06/30/2015
Residency Children's Hospital of Pittsburgh of UPMC Date Completed: 06/30/2014
Medical School Boston University School of Medicine Date Completed: 05/14/2011
Fetal Center MocD patient
Patient Story

A Family's Journey with Rare Disease

Ghaith was born in March of 2023, via uncomplicated Cesarean section at Nationwide Children's Hospital. Ten minutes later, he made history by receiving his first infusion of a medication that effectively halted the damage that had started to accumulate in his brain as a result of molybdenum cofactor deficiency (MoCD) type A.